3-iodobenzylguanidine has been researched along with dihydropyridines in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Ito, S; Nakaya, Y; Nishikado, A; Nomura, M; Uehara, K | 1 |
| Fukuchi, M; Iwasaki, T; Masai, M; Naruse, H; Ohyanagi, M; Sakaki, T; Takahashi, K | 1 |
| Doi, O; Mori, N; Nawada, R; Obayashi, K; Sakata, K; Tamekiyo, H; Yoshida, H | 1 |
| Adachi, Y; Azuma, A; Ito, K; Kato, S; Matsubara, H; Nishikawa, S; Sugihara, H | 1 |
| Ito, S; Kawano, T; Koshiba, K; Mikawa, J; Nada, T; Nomura, M | 1 |
1 trial(s) available for 3-iodobenzylguanidine and dihydropyridines
| Article | Year |
|---|---|
Comparative effect of clinidipine and quinapril on left ventricular mass in mild essential hypertension.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Dihydropyridines; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Quinapril; Radionuclide Imaging; Tetrahydroisoquinolines; Time Factors | 2003 |
4 other study(ies) available for 3-iodobenzylguanidine and dihydropyridines
| Article | Year |
|---|---|
Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Topics: 3-Iodobenzylguanidine; Adult; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Electrocardiography; Female; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Iodine Radioisotopes; Male; Nitrophenols; Organophosphorus Compounds; Radionuclide Imaging; Spectrum Analysis; Sympathetic Nervous System; Tachycardia; Treatment Outcome | 2003 |
Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts.
Topics: 3-Iodobenzylguanidine; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart; Heart Conduction System; Heart Rate; Male; Nifedipine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Sympathetic Nervous System | 2003 |
[Clinical usefulness of a dual L/N-type Ca2+ channel blocker, cilnidipine, in patients with chronic heart failure: assessment with 123I-MIBG myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Calcium Channel Blockers; Dihydropyridines; Female; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
Topics: 3-Iodobenzylguanidine; Adipokines; Aged; Antihypertensive Agents; Antioxidants; Arteriosclerosis; Autonomic Nervous System; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiomegaly; Carotid Arteries; Catecholamines; Cytokines; Dihydropyridines; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Pulse; Radionuclide Imaging; Radiopharmaceuticals | 2007 |